BridgeBio Pharma, Inc. (BBIO)
72.71
+1.04
(+1.45%)
USD |
NASDAQ |
Dec 10, 16:00
72.71
0.00 (0.00%)
After-Hours: 20:00
BridgeBio Pharma Cash from Investing (Quarterly): 4.464M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc. | -2.43B |
| Alnylam Pharmaceuticals, Inc. | 501.11M |
| Supernus Pharmaceuticals, Inc. | 48.71M |
| Ionis Pharmaceuticals, Inc. | 91.34M |
| Regeneron Pharmaceuticals, Inc. | -402.90M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -109.57M |
| Cash from Financing (Quarterly) | -0.894M |
| Free Cash Flow | -597.61M |
| Free Cash Flow Per Share (Quarterly) | -0.5861 |
| Free Cash Flow to Equity (Quarterly) | -139.77M |
| Free Cash Flow to Firm (Quarterly) | -100.80M |
| Free Cash Flow Yield | -4.31% |